ZES

[3-(4-BROMO-2-FLUORO-BENZYL)-7-CHLORO-2,4-DIOXO-3,4-DIHYDRO-2H-QUINAZOLIN-1-YL]-ACETIC ACID

Find entries where: ZES

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	[3-(4-BROMO-2-FLUORO-BENZYL)-7-CHLORO-2,4-DIOXO-3,4-DIHYDRO-2H-QUINAZOLIN-1-YL]-ACETIC ACID
Identifiers	2-[3-[(4-bromo-2-fluoro-phenyl)methyl]-7-chloro-2,4-dioxo-quinazolin-1-yl]ethanoic acid
Formula	C₁₇ H₁₁ Br Cl F N₂ O₄
Molecular Weight	441.636
Type	NON-POLYMER
Isomeric SMILES	c1cc2c(cc1Cl)N(C(=O)N(C2=O)Cc3ccc(cc3F)Br)CC(=O)O
InChI	InChI=1S/C17H11BrClFN2O4/c18-10-2-1-9(13(20)5-10)7-22-16(25)12-4-3-11(19)6-14(12)21(17(22)26)8-15(23)24/h1-6H,7-8H2,(H,23,24)
InChIKey	SXONDGSPUVNZLO-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	37
Chiral Atom Count	0
Bond Count	39
Aromatic Bond Count	17

Drug Info: DrugBank

DrugBank ID	DB02132
Name	Zenarestat
Groups	experimental
Synonyms	Zenarestat
Indication	Investigated for use/treatment in neuropathy (diabetic).
Categories	Aldehyde Reductase, antagonists & inhibitors Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring
CAS number	112733-06-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Aldose reductase	MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQ...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682